A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Recruiting · NCT06067841 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-08-10 | NCT06067841 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Leon Berard | Lyon Cedex08 | France | 6 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Duke Cancer Institute | Durham | United States | 47 |
| Florida Cancer Specialists Sarasota Drug Development Unit | Sarasota | United States | 1 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Gustave Roussy | Villejuif | France | 15 |
| Institut Paoli-Calmettes | Marseille | France | 1 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| NEXT Oncology | San Antonio | United States | 70 |
| Stanford Cancer Center | Palo Alto | United States | 18 |